Cargando…

Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative

A compound containing both CNDP (3‐cyano‐2,6‐dihydroxypyridine), an inhibitor of 5‐fluorouracil (5‐FU) degradation, and EM‐FU (1‐ethoxymethyl‐5‐fluorouracil), a masked form of 5‐FU, was synthesized and named BOF‐A2 (3‐[3‐(6‐benzoyloxy‐3‐cyano‐2‐pyridyloxycarbonyl)benzoyl]‐1‐ethoxymethyl‐5‐fluorourac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujii, Setsuro, Fukushima, Masakazu, Shimamoto, Yuji, Ohshimo, Hideyuki, Imaoka, Takeshi, Shirasaka, Tetsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917705/ https://www.ncbi.nlm.nih.gov/pubmed/2498252 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02286.x

Ejemplares similares

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

Oral Administration of BOF‐A2 to Rats with Lung Transplanted Tumors Results in Increased 5‐Fluorouracil Levels
por: Miyauchi, Shun, et al.
Publicado: (1994)

Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine
por: Shimamoto, Yuji, et al.
Publicado: (2001)

Barrel-muon-spectrometer: BOG-BOF
Publicado: (2005)

BoF Session - CERNBox and Sync&Share storage solutions
por: Gonzalez Labrador, Hugo
Publicado: (2023)

Using Carbonated BOF Slag Aggregates in Alkali-Activated Concretes
por: Mastali, Mohammad, et al.
Publicado: (2019)

Geometric Characteristics of BOF Slag Coarse Aggregate and its Influence on Asphalt Concrete
por: Kong, Dezhi, et al.
Publicado: (2019)

Influence of BOF and GGBFS Based Alkali Activated Materials on the Properties of Porous Concrete
por: Kuo, Wen-Ten, et al.
Publicado: (2019)

Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil
por: Xiong, Jing, et al.
Publicado: (2009)

Considering the Spatial Layout Information of Bag of Features (BoF) Framework for Image Classification
por: Mu, Guangyu, et al.
Publicado: (2015)

Growth, Stratification, and Liberation of Phosphorus-Rich C(2)S in Modified BOF Steel Slag
por: Rao, Lei, et al.
Publicado: (2020)

Research Progress on Skid Resistance of Basic Oxygen Furnace (BOF) Slag Asphalt Mixtures
por: Li, Song, et al.
Publicado: (2020)

Blended Cement Mixed with Basic Oxygen Steelmaking Slag (BOF) as an Alternative Green Building Material
por: Jexembayeva, Assel, et al.
Publicado: (2020)

Screening of Differentially Expressed Genes in 5‐Fluorouracil‐resistant Human Gastrointestinal Tumor Cells
por: Takechi, Teiji, et al.
Publicado: (2001)

Development History and Concept of an Oral Anticancer Agent S-1 (TS-1(®)): Its Clinical Usefulness and Future Vistas
por: Shirasaka, Tetsuhiko
Publicado: (2009)

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
por: Tong, Jingtao, et al.
Publicado: (2011)

Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel
por: Yi, Hee, et al.
Publicado: (2010)

The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil
por: Naguib, Youssef W., et al.
Publicado: (2014)

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma
por: GUO, XU-FENG, et al.
Publicado: (2015)

BOF steel slag as a low-cost sorbent for vanadium (V) removal from soil washing effluent
por: Gao, Yuchen, et al.
Publicado: (2017)

Novel poly-β-cyclodextrin derivatives as advanced carriers for 5-fluorouracil for tumor: the impact of charge on antitumor efficiency
por: Li, Hailang, et al.
Publicado: (2020)

Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
por: Deng, Lifen, et al.
Publicado: (2013)

In vitro additive antitumor effects of dimethoxycurcumin and 5‐fluorouracil in colon cancer cells
por: Zhao, Huiying, et al.
Publicado: (2017)

A Novel Class of Antitumor Prodrug, 1‐(2′‐Oxopropyl)‐5‐fluorouracil (OFU001), That Releases 5‐Fluorouracil upon Hypoxic Irradiation
por: Shibamoto, Yuta, et al.
Publicado: (2000)

Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis
por: SHIMAMOTO, YUJI, et al.
Publicado: (2016)

Synthesis and Biological Evaluation of New 5-Fluorouracil-Substituted Ampelopsin Derivatives
por: Zhou, Wei-Ming, et al.
Publicado: (2010)

Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells
por: Inaba, Makoto, et al.
Publicado: (1996)

Molecular Insights on the Cyclic Peptide Nanotube-Mediated Transportation of Antitumor Drug 5-Fluorouracil
por: Liu, Huifang, et al.
Publicado: (2010)

Synthesis, Structure and Antitumor Activity of Dibutyltin Oxide Complexes with 5-Fluorouracil Derivatives. Crystal Structure of [(5-Fluorouracil)-1-CH(2)CH(2)COOSn(n-Bu) (2)](4)O(2)
por: Zuo, Dai-shu, et al.
Publicado: (2001)

Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5‐Fluorouracil
por: Ishikawa, Yoichiro, et al.
Publicado: (2000)

Antitumor effects and the underlying mechanism of licochalcone A combined with 5-fluorouracil in gastric cancer cells
por: Lin, Xiaolin, et al.
Publicado: (2017)

The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells
por: Țigu, Adrian Bogdan, et al.
Publicado: (2020)

Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo
por: Di Paolo, Antonello, et al.
Publicado: (2017)

Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes
por: Yamamiya, Ikuo, et al.
Publicado: (2013)

A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma
por: Kobayashi, Kazuma, et al.
Publicado: (2006)

Study on fluorouracil–chitosan nanoparticle preparation and its antitumor effect
por: Chen, Gaimin, et al.
Publicado: (2016)

Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function
por: Goto, Keiko, et al.
Publicado: (2019)

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
por: Nakamura, Ayako, et al.
Publicado: (2013)

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
por: Shimamoto, Yuji, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_5hn60i6skcpdqnnpfb2o2tb8ac